4:46 PM ET
8-K
Shareholder Meeting
Cardio Diagnostics Holdings Shareholder Meeting
Cardio Diagnostics Holdings held its 2026 Annual Meeting of Stockholders on September 18, 2026, where shareholders elected seven directors and ratified Prager Metis CPAs LLC as the independent auditor. Additionally, stockholders approved the potential future issuance of common stock exceeding 20% of outstanding shares in non-public transactions, as required by Nasdaq Listing Rule 5635(d).